Nov 13, 2025
Our Base Editing Cancer Study Awarded “Paper of the Quarter” by DG-GT!
We’re thrilled to share that our recent study, "A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs," has been selected as one of the top three "Papers of the Quarter" by the German Society for Gene Therapy (DG-GT)!